Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QRFPR | Q96P65 | 3/20 | 0.42 |
| ▸ | NMT1 | P30419 | 5/20 | 0.38 |
| ▸ | NMT2 | O60551 | 4/20 | 0.38 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 1/20 | 0.36 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.35 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.35 |
| ▸ | NPY1R | P25929 | 1/20 | 0.34 |
| ▸ | NPY2R | P49146 | 1/20 | 0.34 |
| ▸ | NPY4R | P50391 | 1/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
| ▸ | GNPAT | O15228 | 1/20 | 0.34 |
| ▸ | TFPI | P10646 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630598 | 0.95 | QRFPR (0.42) | QRFPRNMT1NMT2C3AR1TLR2 | |
| SCHEMBL29875551 | 0.94 | C3AR1 (0.40) | QRFPRC3AR1NOD1SLC15A2NPY1R | |
| SCHEMBL31127533 | 0.92 | QRFPR (0.47) | QRFPRNMT1NMT2TLR2NPY1R | |
| SCHEMBL31636034 | 0.91 | QRFPR (0.42) | QRFPRNMT1NMT2C3AR1TLR2 | |
| SCHEMBL5606065 | 0.91 | QRFPR (0.42) | QRFPRNMT1NMT2C3AR1TLR2 | |
| SCHEMBL5606063 | 0.91 | QRFPR (0.42) | QRFPRNMT1NMT2C3AR1TLR2 | |
| SCHEMBL30826350 | 0.91 | NPY4R (0.47) | QRFPRNMT1NMT2NPY1RNPY2R | |
| SCHEMBL30027024 | 0.90 | NMT1 (0.44) | QRFPRNMT1NMT2C3AR1TLR2 | |
| SCHEMBL31593243 | 0.89 | SLC15A2 (0.43) | QRFPRNMT1NMT2C3AR1TLR2 | |
| SCHEMBL30481161 | 0.88 | NOD1 (0.43) | QRFPRNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |